UBS Group’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61.8K Buy
17,269
+13,080
+312% +$46.8K ﹤0.01% 6318
2025
Q1
$10.6K Buy
4,189
+1,636
+64% +$4.16K ﹤0.01% 7299
2024
Q4
$9.83K Buy
2,553
+1,665
+188% +$6.41K ﹤0.01% 7099
2024
Q3
$2.42K Sell
888
-17,555
-95% -$47.9K ﹤0.01% 7217
2024
Q2
$48.9K Sell
18,443
-17,440
-49% -$46.2K ﹤0.01% 5562
2024
Q1
$84.7K Buy
35,883
+803
+2% +$1.9K ﹤0.01% 5140
2023
Q4
$86.1K Buy
35,080
+17,380
+98% +$42.7K ﹤0.01% 5064
2023
Q3
$47.8K Sell
17,700
-2,812
-14% -$7.59K ﹤0.01% 5188
2023
Q2
$70.8K Buy
20,512
+19,670
+2,336% +$67.9K ﹤0.01% 5209
2023
Q1
$3.55K Buy
+842
New +$3.55K ﹤0.01% 7204
2022
Q2
Sell
-3,473
Closed -$10K 9498
2022
Q1
$10K Sell
3,473
-617
-15% -$1.78K ﹤0.01% 7364
2021
Q4
$12K Buy
4,090
+668
+20% +$1.96K ﹤0.01% 7437
2021
Q3
$10K Sell
3,422
-15,684
-82% -$45.8K ﹤0.01% 6857
2021
Q2
$88K Buy
19,106
+13,070
+217% +$60.2K ﹤0.01% 4935
2021
Q1
$21K Sell
6,036
-5,980
-50% -$20.8K ﹤0.01% 6316
2020
Q4
$72K Sell
12,016
-786
-6% -$4.71K ﹤0.01% 4923
2020
Q3
$93K Sell
12,802
-31,790
-71% -$231K ﹤0.01% 4399
2020
Q2
$400K Buy
44,592
+29,592
+197% +$265K ﹤0.01% 3559
2020
Q1
$113K Buy
15,000
+14,898
+14,606% +$112K ﹤0.01% 4332
2019
Q4
$1K Buy
+102
New +$1K ﹤0.01% 6872